A COMPARATIVE STUDY ON RISK ANALYSIS IN MULTIDRUG-RESISTANT TUBERCULOSIS POPULATION OF TELANGANA STATE (INDIA)

• In: C6 - Short oral presentations – focus on practice on Thursday, 1 October 2015, 09:00-17:30
• At: Düsseldorf (Germany) (2015)
• Type: Presentation
• By: BOMPELLI, Anusha (St. Peter's Institute of Pharmaceutical Sciences, Pharmacy Practice, Hanamkonda, India)
• Co-author(s): Anusha Bompelli
  
• Abstract:

  The previous treatment for tuberculosis (TB) is the strongest risk factor for development of multidrug-resistant (MDR) TB. The current scenario states that even treatment naïve patients are also at risk. It is necessary to identify the group at high risk.

   

  A prospective observational study was carried out over a period of 9 months in govt.

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login